AZD8931
848942-61-0
99%
2026-07-20
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Description
ProductName AZD8931 Cat No CEI-0064 Description AZD8931 can inhibit EGFR and Erbb2 with IC50 of 12 nM and 14 nM. CAS No 848942-61-0 Molecular Weight 473.93 Purity >99% Storage 2 years at -20 centigrade Targets EGFR, Erbb2 Molecular Formula C23H25ClFN5O3 Chemical Name 2-(4-(4-(3-chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-N-methylacetamide Solubility DSMO 40 mg/mL Water In vitro AZD8931 can inhibit EGFR and Erbb2 with IC50 of 12 nM and 14 nM. AZD8931 has equipotent activity against signaling by three members of this family (epidermal growth factor receptor, erbB2, and erbB3). AZD8931 shows simultaneous, potent inhibition and delivers greater antitumor activity in experimental models than standard agents such as gefitinib or lapatinib. AZD8931 was the most potent inhibitor of erbB2 (IC50, 3 nmol/L) and erbB3 (IC50, 4 nmol/L) phosphorylation and was significantly more potent that either gefitinib or lapatinib for both erbB2. In vivo Oral dosing of AZD8931 significantly inhibited BT474c (breast), Calu-3 (NSCLC), LoVo (colorectal), FaDu (SCCHN), and PC-9 (NSCLC) tumor xenograft growth. AZD8931 causes pharmacodynamic changes in proliferation and apoptosis markers in human tumor xenograft models. category Inhibitors(c1514) cas_num 848942-61-0 Basic Info-
Product Name:
Sapitinib
Other Name:1-Piperidineacetamide,4-[[4-[(3-chloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-N-methyl-;4-[[4-[(3-Chloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-N-methyl-1-piperidineacetamide;4-(3-Chloro-2-fluoroanilino)-7-methoxy-6-[[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy]quinazoline;AZD 8931;Sapitinib;Sapatinib;2-[4-[4-(3-Chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide
CAS No.:848942-61-0
Molecular Formula:C23H25ClFN5O3
InChIKeys:InChIKey=DFJSJLGUIXFDJP-UHFFFAOYSA-N
Molecular Weight:473.9277032
Exact Mass:473.93
EC Number:-0
Categories:
Characteristics-
PSA:
88.6
XLogP3:4
Density:1.3±0.1 g/cm3
Boiling Point:632.8±55.0°C at 760 mmHg
Flash Point:336.5±31.5 °C
Refractive Index:1.627
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Reproductive toxicity, Category 1B
Specific target organ toxicity â repeated exposure, Category 1
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Danger
Hazard statement(s) H302 Harmful if swallowed
H360 May damage fertility or the unborn child
H372 Causes damage to organs through prolonged or repeated exposure
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P318 IF exposed or concerned, get medical advice.
P319 Get medical help if you feel unwell.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product